eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...

“Although dietary interventions were once considered ineffective for managing lipedema, emerging evidence increasingly supports the therapeutic potential of CHO reduction in alleviating lipedema symptoms.” (Reedy et al., 2025)
Lipedema, a disorder of fat accumulation, has limited treatment options. Evidence suggests that dietary carbohydrate restriction – a ketogenic diet, specifically – may be effective for targeting stubborn lipedema fat, as well as for decreasing pain and inflammation and improving quality of life even in the absence of significant weight loss. However, a strict ketogenic diet can be difficult to adhere to consistently, and, like any dietary or lifestyle change, successful implementation requires attention to comorbidities, cultural issues, mental health, capacity for change, and other factors.
A paper in Recent Progress in Nutrition provides a comprehensive framework for tailoring a low-carb nutritional strategy to patient needs and preferences specifically in the context of lipedema. This patient-centered, holistic approach starts by acknowledging that therapeutic carbohydrate restriction (TCR) encompasses a wide range of carbohydrate intake, and that benefits can be experienced even when carbs are not reduced to a ketogenic level (typically < 50 g/day, and often < 20-30 g/day).
Insulin sensitivity and carbohydrate tolerance vary widely among individuals, and a more generous carbohydrate intake of up to 130 g/day allows flexibility for those who prefer a vegetarian approach, whereas staying at the very low end of carb intake facilitates a larger intake of animal foods. It is noted, however, that some of the therapeutic benefits of carbohydrate restriction may not be realized unless someone does limit carbs to the point of generating ketones.
The paper covers common comorbidities with lipedema, such as hypothyroidism, sleep disorders, chronic venous disease, and others, and the role of TCR in improving these, with mention of specific nutrients that may be beneficial for addressing these, and those that may exacerbate them.
Beyond the “nuts and bolts” of TCR for lipedema, the authors also address critical psychological aspects of dietary change, particularly related to a condition that can so dramatically reduce quality of life. The patient-centered holistic approach presented includes guidance on addressing depression and anxiety, socioeconomic status, the importance of community, cultural and ethnic influences, and more. All of these can affect capacity for change and capacity to adhere to any dietary or lifestyle change, not just reducing carbohydrates.
Submit this form and you'll receive our latest news and updates.
With ever-increasing applications emerging for therapeutic ketogenic diets, it’s important for healthcare professionals ...
Learn moreThe Society of Metabolic Health Practitioners recently published a position statement on therapeutic carbohydrate reduct...
Learn moreResearchers from Harvard’s Chan School of Public Health recently published an analysis of the association between low ca...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment